How to buy Aziyo Biologics stock (Aziyo Biologics)

Aziyo Biologics is a medical devices business based in the US. Aziyo Biologics shares (AZYO) are listed on the NASDAQ and all prices are listed in US Dollars. Aziyo Biologics employs 151 staff and has a trailing 12-month revenue of around $48.4 million.

Our top picks for where to buy Aziyo Biologics Inc stock

Buy Aziyo Biologics stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Aziyo Biologics stock price (NASDAQ: AZYO)

Use our graph to track the performance of AZYO stocks over time.

Aziyo Biologics shares at a glance

• Key figures

Information last updated 2024-06-30.

52-week range	$0.00 - $0.00
50-day moving average more info button	$1.46
200-day moving average more info button	$2.52
Wall St. target price	$10.50
PE ratio more info button	N/A
Dividend yield more info button	$0 (0%)
Earnings per share (TTM) more info button	$-2.18

Is it a good time to buy Aziyo Biologics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Aziyo Biologics financials

Revenue TTM	$48.4 million
Gross profit TTM	$19.2 million
Return on assets TTM	-28.75%
Return on equity TTM	-775.14%
Profit margin	-70.13%
Book value	$-1.36
Market Capitalization more info button	$24.2 million

TTM: trailing 12 months

Aziyo Biologics share dividends

We're not expecting Aziyo Biologics to pay a dividend over the next 12 months.

You may also wish to consider:

Aziyo Biologics share price volatility

Over the last 12 months, Aziyo Biologics's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Aziyo Biologics's is -0.0846. This would suggest that Aziyo Biologics's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Aziyo Biologics has bucked the trend.

To put Aziyo Biologics's beta into context you can compare it against those of similar companies.

• Vertex Pharmaceuticals (VRTX.US): 0.394
• Biogen (BIIB.US): -0.061
• Moderna (MRNA.US): 1.69

Aziyo Biologics overview

Aziyo Biologics, Inc. , a regenerative medicine company, focuses on the development of regenerative products to address the device protection, women's health, orthobiologics, cardiovascular, and soft tissue reconstruction markets. It offers CanGaroo that combines the envelope with antibiotics and is designed to reduce the risk of infection following surgical implantation of an electronic device. The company also provides cardiovascular products, such as ProxiCor for use as an intracardiac patch or pledget for tissue repairs; Tyke for use in neonates and infants to repair pericardial structures; and VasCure, a patch material to repair or reconstruct the peripheral vasculature, including the carotid, renal, iliac, femoral, and tibial blood vessels for cardiovascular, vascular, and general surgeons. In addition, it offers Fiber VBM, ViBone, and OsteGro V that are human tissue-derived bone allografts designed to protect and preserve native bone cells; and SimpliDerm, a pre-hydrated HADM designed to repair or replacement of damaged or inadequate integumental tissues. Further, the company provides contract manufacturing services for various products to corporate customers. It sells its products to hospitals and other healthcare facilities through its direct sales force, commercial partners, and independent sales agents.

Frequently asked questions

null
What percentage of Aziyo Biologics is owned by insiders or institutions?
Currently 2.181% of Aziyo Biologics shares are held by insiders and 70.442% by institutions. How many people work for Aziyo Biologics?
Latest data suggests 151 work at Aziyo Biologics. When does the fiscal year end for Aziyo Biologics?
Aziyo Biologics's fiscal year ends in December. Where is Aziyo Biologics based?
Aziyo Biologics's address is: 12510 Prosperity Drive, Silver Spring, MD, United States, 20904 What is Aziyo Biologics's ISIN number?
Aziyo Biologics's international securities identification number is: US05479K1060